SavedAdd your journal

Journals / Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi / 2015 / Cilt: 6 - Sayı: 1

Role of microRNAs (miRNAs) in tumor angiogenesis

Tümör anjiyogenezinde mikroRNA (miRNA)'ların rolü

TUĞBA SEMERCİ SEVİMLİ
NURTEN ÖZÇELİK
MURAT SEVİMLİ
Pages
43–46
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Key words: Cancer, angiogenesis, miRNA

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Angiogenesis is a controlled process that occurs in; developmental events of embryonic and post embryonic periods, wound and tissue healing and also events of female reproductive system.
📊
Key Findings & Data:For these reasons in recent years, the interest on miRNAs has increased in the studies aiming to understand molecular basis of cancer and treatment of it.
💡
Conclusion & Impact:Key words: Cancer, angiogenesis, miRNA
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kanser · anjiyogenez · miRNA

Abstract

Angiogenesis is a controlled process that occurs in; developmental events of embryonic and post embryonic periods, wound and tissue healing and also events of female reproductive system. Nevertheless angiogenesis can be observed as an uncontrolled and so a pathological process in cancers, some inflamtory diseases and eye diseases. miRNAs are non protein coding small RNA molecules. The researches shoved that miRNAs play some important roles in the cell. Also the expression changes of some miRNAs is associated with angiogenesis and cancer development. For these reasons in recent years, the interest on miRNAs has increased in the studies aiming to understand molecular basis of cancer and treatment of it. Key words: Cancer, angiogenesis, miRNA

Özet

Anjiyogenez; embriyonik-post-embriyonik dönemde gelişme, yara ve doku hasarlarının iyileştirilmesi ve dişi üreme sistemindeki olaylarda, kontrol altında gerçekleşmekte olan bir süreçtir. Kanserler, bazı inflamatuvar durumlar ve göz hastalıklarında kontrolsüz gerçekleşip patolojik bir durum olarak gözlenmektedir. miRNA'lar protein kodlamayan küçük RNA molekülleridir. Yapılan araştırmalar, miRNA'ların hücrede önemli roller üstlendiğini göstermiştir. Ayrıca bazı miRNA'ların ekspresyonlarının değişimi, kanser gelişimiyle ve anjiyogenezle ilişkilendirilmiştir. Bu nedenle son yıllarda ilgi kanserin moleküler temelinin anlaşılması ve tedavisine yönelik çalışmalarda miRNA'lara olan ilgi artmıştır. Anahtar kelimeler: Kanser, anjiyogenez, miRNA

🔖

Cite This Article

SEVİMLİ, T. S., ÖZÇELİK, N., SEVİMLİ, M. (2015). Role of microRNAs (miRNAs) in tumor angiogenesis. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 6 - Sayı: 1, 43–46. https://ajindex.com/articles/363317

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Tekeli SÖ, Emerk K. Endotel progenitör hücreleri. Marmara Medical Journal 2007; 20(1): 59-65.
  2. Olgar Ş, Yetgin S. Anjiogenezis. Çocuk Sağlığı ve Hastalıkları Dergisi 2003;(46): 139-147.
  3. Turgut B, Mete Güler M, Demir T, Türkçüoğlu P, Çeliker Ü. Oküler anjiyogenezde vasküler endotelyal büyüme faktörünün rolü. Türkiye Klinikleri Oftalmoloji Dergisi 2007; 16(1): 38-46.
  4. Tepper OM, Sealove BA, Murayama T, Asahara T.Newly. Emerging concepts in blood vessel growth: recent discovery of endothelial progenitor cells and their function in tissue regeneration. Journal of Investigative Medicine 2003; 51(6): 353-359.
  5. Kılıç D, Yıldırım Ö, Şahin S, Pamir MN. Glial tümörlerin anjiyogenezi. Türk Nöroşirürji Dergisi 2005; 15(1): 1-9.
  6. Folkman J, Shing Y. Angiogenesis. The Journal of Biological Chemistry 1992; 267(16): 10931-10934.
  7. Menakuru SR, Brown NJ, Staton CA, Reed MW. Angiogenesis in pre-malignant conditions. British Journal of Cancer 2008; 99(12): 1961-1966.
  8. Gupta, M. K. and Qin, R. Y. Mechanism and its regulation of tumor-induced angiogenesis. World Journal of Gastroenterology 2003; (9): 1144-1155.
  9. Liekens, S, De Clercq E, Neyts J. Angiogenesis: regulators and clinical applications. Biochemical Pharmacology 2001;(61): 253-270. Özuysal S. Tümoral anjiogenezis. Türk Patoloji Dergisi 2001; 17(3-4): 90-93. Konukoğlu D. Turhan MS. Anjiyogenezin temel moleküler mekanizmaları ve tümör anjiyogenezi. Cerrahpaşa Tıp Dergisi 2004; 36(1): 42-48.
  10. Zhang T, Niu X, Liao L, Cho EA, Yang H. The contributions of hıf-target genes to tumor growth in RCC. PLoS One 2013; 8(11): e80544. Kim LC, Song L, Haura EB. Src kinases as therapeutic targets for cancer. Nature Reviews Clinical Oncology 2009; 6(10): 587-595.
  11. Cheng Q, Yi B, Wang A, Jiang X. Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis. Journal of OncoTargets and Therapy 2013;(6): 1675-1684.
  12. Vimalraj S, Miranda PJ, Ramyakrishna B, Selvamurugan N. Regulation of breast cancer and bone metastasis by microRNAs. Disease Markers 2013; 35(5): 369-387.
  13. Kwak PB, Iwasaki S, Tomari Y. The microRNA pathway and cancer. Cancer Science 2010; (101): 2309-2315.
  14. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the USA 2004;(101): 2999–3004.
  15. Le Quesne J, Caldas C. Micro-RNAs and breast cancer. Moleculer Oncology 2010;(4): 230-241.
  16. Saydam F, Değirmenci İ